Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, March 2001, p. 776-780, Vol. 45, No. 3
Critical Care Medicine Department, Warren
Grant Magnuson Clinical Center, National Institutes of Health,
Bethesda, Maryland
Received 27 September 2000/Returned for modification 27 November
2000/Accepted 11 December 2000
Recent studies have shown that point mutations in the
dihydropteroate synthase (DHPS) gene of human-derived
Pneumocystis carinii are related to exposure to sulfa drugs
and possibly represent the emergence of sulfa resistance. We developed
a simple single-strand conformation polymorphism (SSCP) method to
permit rapid detection of these mutations. With plasmid constructs,
SSCP was able to detect as little as 10% of a minority population. The
SSCP assay was compared to direct sequencing for typing the DHPS gene
by examining 37 clinical isolates with known DHPS sequences and 41 clinical isolates with unknown DHPS sequences. The typing results were
consistent between these two methods for all isolates except 11 in
which mutations were detected by SSCP but not by direct sequencing.
Sequencing of individual clones after subcloning confirmed the presence
of mutations in a minority population as determined by SSCP. SSCP is a
very simple and sensitive method for rapid identification of P. camii DHPS mutations.
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.3.776-780.2001
Rapid Detection of Mutations in the Human-Derived
Pneumocystis carinii Dihydropteroate Synthase Gene
Associated with Sulfa Resistance
*
Corresponding author. Mailing address: Building 10, Room 7D43, National Institutes of Health, 10 Center Dr. MSC 1662, Bethesda, MD 20892-1662. Phone: (301) 496-9907. Fax: (301) 402-1213. E-mail: jkovacs{at}nih.gov.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»